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This study was designed to assess the effects of blood-free reper-
fusion with oxygenated or unoxygenated intracoronary perftuoro-
chemical (Fluosol-DA 20%) on myocardial perfusion and to 
determine its mechanism or mechanisms of limiting no reftow. 
Twenty-four dogs underwent 90 min of coronary occlusion fol-
lowed by 210 min of reperfusion and were randomized to either: 
1) blood-free reperfusion with intracoronary oxygenated perftuo-
rochemical (20 mIlkg per min) for 20 min followed by blood 
reperfusion (n = 8); 2) intracoronary unoxygenated perftuoro-
chemical administered as in those treated with oxygenated perftu-
orochemical (n = 8); and 3) blood reperfusion alone (control) (n = 
8). Regional myocardial blood ftow was serially determined and 
global myocardial perfusion was assessed by an intravenous 
injection of the ftuorescent dye (thioftavin-S). Quantitative studies 
were performed to determine neutrophil infiltration and extent of 
endothelial injury. 
Hemodynamic variables were similar in all groups. The zone of 
impaired perfusion (thioftavin negative), expressed as a percent of 
Reestablishing blood flow to jeopardized myocardium after 
acute coronary occlusion remains the most effective way to 
limit myocardial necrosis and improve ventricular function 
(1-4). However, the beneficial effects of reperfusion after 
prolonged coronary occlusion may be limited by an incom-
plete return of blood flow to some areas of the ischemic 
myocardium, which may result in the conversion of revers-
ibly injured myocytes to irreversible injury (5). This obser-
vation has been termed the "no reflow phenomenon." The 
endothelium of the microvasculature and neutrophilic infil-
trates are thought to playa fundamental role in the patho-
genesis of the no reflow phenomenon (5,6). 
Perfluorochemical (Fluosol-DA 20%, Alpha Therapeutic 
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the left ventricle, averaged 10 ± 2%, 6 ± 2% and 3 ± 1%, in 
control and unoxygenated and oxygenated perftuorochemical 
groups, respectively (control versus oxygenated perftuorochemical 
p < 0.004). The reduction in thioftavin-negative area with oxy-
genated perftuorochemical was associated with a notable recovery 
of endocardial blood ftow (0.97 ± 0.22 vs. control 0.39 ± 
0.08 mllmin per g; p < 0.04) at 210 min of reperfusion. The 
number of capillaries plugged by neutrophils (per 200 capillaries) 
in thioftavin-negative areas was similar with both oxygenated (5.9 
± 1.4) and unoxygenated perftuorochemical (5.4 ± 0.8) treatment 
and was significantly less than that with the control group (18.9 ± 
3.2, p < 0.003). 
Myocardium reperfused with oxygenated perftuorochemical 
demonstrated significantly greater preservation of endothelial 
structure. These findings suggest that blood-free reperfusion with 
oxygenated perftuorochemical reduces the area of no reftow 
through better endothelial cell preservation. 
(J Am Coll CardioI1991;18:215-23) 
Corp.), an acellular perfusate, has been shown to reduce 
infarct size and improve myocardial blood flow (7-11). 
However, these studies did not measure the area of no 
reflow and were limited to observational analysis of endo-
thelial injury and suppression of neutrophil infiltration. Fur-
thermore, these studies, utilizing either intracoronary infu-
sion of Fluosol-DA with a patent left main coronary artery or 
intravenous administration of perfluorochemical, allowed 
cellular elements, primarily neutrophils, to enter the isch-
emic bed on reperfusion (9,10). 
The aim of this study was to assess the efficacy of 
blood-free reperfusion with oxygenated Fluosol-DA in lim-
iting no reflow injury in the canine model. In addition, 
quantitative morphologic techniques were used to determine 
the degree and extent of endothelial injury and neutrophil 
plugging of capillaries in the ischemic and nonischemic 
myocardium. 
Methods 
This study conformed to the guidelines specified in the 
"Guide for Care and Use of Laboratory Animals" (DHHS 
publication no. [NIH] 85-23, revised 1985) and was approved 
0735-1097/91/$3.50 
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Figure 1. Summary of experimental protocol. 
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by the Armed Forces Institute of Pathology Animal Care and 
Use Committee. 
Experimental protocol (Fig. 1). Male mongrel dogs weigh-
ing 15 to 23 kg were used for the study. Dogs were anesthe-
tized with intravenous sodium pentobarbital (25 to 30 mg/kg 
body weight), intubated with a cuffed endotracheal tube and 
ventilated with a Harvard positive-pressure respirator. The 
arterial pH was maintained at 7.40 ± 0.05. An electrocardio-
gram was continuously recorded on a Holter monitor with a 
modified Frank lead system. Intravenous morphine sulfate 
and diazepam were used for supplemental anesthesia during 
the procedure. Dogs also received intravenous heparin 
(300 IV/kg). An 8F USCI sheath was inserted into the right 
carotid artery and 7F USCI sheaths were introduced into the 
right and left femoral arteries for measurement of arterial 
blood pressure and withdrawal of blood during blood flow 
measurements. A baseline blood sample was obtained for 
total leukocyte count, hemoglobin and hematocrit. All dogs 
received a 5 ml intravenous bolus injection of reconstituted 
Fluosol-DA before coronary occlusion, which produced a 
transient hypotensive episode (50 to 60 mm Hg) in 70% of the 
dogs. Blood pressure returned to pretest dose levels within 
20 min. This finding is predominantly observed in the canine 
model and has been previously reported (11). 
Regional myocardial blood flow was assessed at baseline 
study before occlusion and serially at 45 min of occlusion 
and 30 and 210 min of reperfusion. The left coronary ostium 
was engaged with an 8F USCI guiding catheter, and a 
0.014 in. (0.36 cm) flexible steerable guide wire was posi-
tioned in the proximal left circumflex coronary artery fol-
lowed by a 3 mm x 2 cm balloon angioplasty catheter 
(Advanced Cardiovascular Systems). The angioplasty cath-
eter was used for coronary occlusion, the monitoring of 
phasic and mean coronary artery pressure (pressure tracings 
were displayed on a model ES-l000 recorder, Gould) and 
administration of perfluorochemical. After 45 min of occlu-
sion, hemodynamic measurements were repeated and myo-
cardial blood flow was determined. 
Lidocaine (1 mg/kg) was administered as an intravenous 
bolus injection just before reperfusion. Balloon inflation was 
maintained for an additional 20 min at the time of reperfusion 
in dogs treated with perfluorochemical to facilitate blood-
free reperfusion. In the control group, the angioplasty bal-
loon was deflated at the time of reperfusion, allowing imme-
diate return of blood flow to the previously ischemic bed. 
After 20 min of reperfusion, patency of the previously 
occluded artery was confirmed by restoration of mean 
coronary blood pressure in the occluded bed. 
Intracoronary perfluorochemical infusion. Dogs were ran-
domized before the start of the experiment to one of the 
following groups: 1) blood-free reperfusion with intracoro-
nary oxygenated perfluorochemical (20 mUkg per min) for 
20 min followed by blood reperfusion (n = 8); 2) intracoro-
nary unoxygenated perfluorochemical administered as in 
those treated with oxygenated perfluorochemical (n = 8); 
and 3) blood reperfusion alone (control; n = 8). Fluosol-DA 
was bubbled with 100% oxygen at a rate of 2 liters/min for 
30 min just before infusion. Perfluorochemical was adminis-
tered into the left circumflex artery through the central 
lumen of the angioplasty catheter using a Medrad IV power 
injector. The volume of Fluosol-DA given over the 20 min 
period was 380 ml for an average weight 19 kg dog. Dogs in 
the perfluorochemical groups were ventilated with 100% 
oxygen during the reperfusion period. Regional myocardial 
blood flow measurements were repeated at 30 and 210 min 
after reperfusion; at these times, blood samples were ob-
tained for total leukocyte count and hemoglobin and hema-
tocrit determinations. Hemodynamic measurements were 
repeated at 30, 120 and 210 min of reperfusion. 
After the last microsphere injection, the area of impaired 
perfusion was delineated by an intravenous injection of the 
fluorescent dye thioflavin-S (1 mllkg, Sigma). The dye was 
prepared fresh as a 4% solution in warm saline solution, 
centrifuged for 10 min at 1,600 rpm to remove particulate 
matter and injected by hand over 15 to 20 s. Immediately 
after injection of thioflavin-S, each dog was rapidly eutha-
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nized by intravenous administration of isotonic potassium 
chloride and the heart was excised. 
Myocardial blood flow determinations. Transmural myo-
cardial blood flow was assessed with use of colored polysty-
rene microspheres. Hale et al. (12) demonstrated that myo-
cardial blood flow measured by colored microspheres is 
comparable with that measured by radioactive tracers. Ap-
proximately 5 to 8 X 106 colored labeled polystyrene micro-
spheres (yellow, red, green and black), 11.9 ± 1.9 pm (E-Z 
Trac, SRP), were mixed by vortex agitation for 5 min and 
hand-injected as a rapid bolus injection through the central 
lumen of the pigtail catheter placed in the apex of the left 
ventricular cavity. Left ventricular injections of micro-
spheres are comparable with left arterial injections (13). 
Reference arterial samples were withdrawn from the femoral 
artery at a constant rate (13.4 mllmin) with a withdrawal 
pump (model 901, Harvard Instruments), beginning 5 s 
before microsphere injection and continuing for 90 s after 
injection. 
At the conclusion of each experiment, the heart was cut 
in 1 cm slices parallel to the atrioventricular groove, and 
mUltiple transmural samples of myocardium (2 to 4 g) were 
taken from the posterior wall supplied by the left circumflex 
coronary artery (ischemic region) and the anterior wall 
(nonischemic region). Samples were further subdivided into 
epicardial and endocardial halves. Blood and tissue samples 
were processed with digestion reagents obtained from E-Z 
Trac, by a modification of a method previously described 
(12). Ethanol was added to each aliquot of blood and tissue 
digest and subsequently evaporated for removal of perfiuo-
rochemical particles. Final aliquots from the blood and 
tissue were counted with a hemocytometer, and four to eight 
chambers were counted for each sample. 
Myocardial blood flow (Qm; mllmin per g) was then 
calculated as follows: Qm = (Cm x Qr)/(Cr x Wt), where Cm 
is the total number of microspheres in the tissue sample, Qr 
is the rate of the reference blood withdrawal (ml/min), Cr is 
the total number of micro spheres in the reference blood 
sample and Wt is the weight of the tissue sample (g). 
Measurement of area of impaired perfusion. Thioflavin-S 
is a fluorescent vital dye (bright yellow-green under ultravi-
olet light) that stains the endothelium of blood vessels (5). 
Areas not perfused by thioflavin-S were determined by 
photographing the myocardial slides under ultraviolet light 
using high speed Ektachrome film (Kodak). An enlarged 
tracing (magnification x5) was made from each slide, and 
thioflavin-negative and -positive areas were then determined 
by computer planimetry of tracings by an observer who had 
no knowledge of the treatment groups. 
Histologic analysis. Multiple myocardial biopsy samples 
were obtained before photographing the heart. Thioflavin-
negative and -positive areas from the posterior wall (isch-
emic region) and anterior wall (nonischemic region) were 
sampled. Tissue was cut into 1 mm3 pieces, fixed in McDow-
ell-Trump solution and stored at 4°C for transmission elec-
tron microscopy. Specimens were transferred to I % osmium 
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Table 1. Scoring Method of Myocardial and Microvascular Injury 
Myocyte Injury 
o Normal myocardium 
Reversible injury 
a) Mild nuclear clumping, mild mitochondrial swelling, 
prominent I bands 
b) Intracellular edema, moderate nuclear changes, mild to 
moderate mitochondrial swelling with some separation of 
cristae 
c) Marked intracellular edema, vacuoles, moderate 
mitochondrial swelling with occasional mitochondria 
demonstrating severe swelling, clearing of mitochondrial 
matrices, occasional focal clumping of cristae 
2 Irreversible injury 
a) Presence of flocculent densities within mitochondria, 
including the above changes 
Endothelial Injury 
o Normal endothelium 
0.5 Mild endothelial swelling with decreased pinocytotic vesicles 
1.0 Moderate endothelial swelling with decreased pinocytotic 
vesicles 
1.5 Severe endothelial cell swelling and/or membrane-bound 
vesicles, myelin figures 
2.0 Endothelial cell protrusions, membrane-bound vesicles, 
myelin figures 
3.0 Red blood stacking with and without endothelial cell swelling 
4.0 Platelets and fibrin deposition with and without endothelial 
cell swelling 
5.0 Leukocyte adhesion with and without endothelial cell swelling 
6.0 Loss or disintegration of endothelium with and without 
endothelial cell swelling 
tetroxide in 0.1 M cacodylate buffer, dehydrated and em-
bedded in effapoxy (Fullam Co.). Semi-thin sections (0.5 to 
2 pm) were cut, stained with 1% toluidine blue and examined 
by light microscopy. An average of four biopsy specimens 
each from the thioflavin-negative and -positive areas of the 
ischemic myocardium and two specimens each from the 
nonischemic endocardium and epicardium were obtained. 
Areas with the most capillaries were selected for ultrathin 
section cutting, stained with uranyl acetate and lead citrate 
and examined with a Zeiss 109 IGF electron microscope. 
Light microscopy. Myocardial sections obtained from the 
ischemic areas (thioflavin-negative and thioflavin-positive) 
and the nonischemic endocardial and epicardial (thioflavin-
positive) regions were examined under light microscopy by 
an observer who had no knowledge of other data using an oil 
immersion objective (lOOx) and a lOx eyepiece. A total of 
200 capillaries were randomly selected from each section 
and the total number of leukocytes within these capillaries 
were quantitated. Approximately 90% of the capillaries 
counted per section were cut in cross section. The remaining 
were longitudinally cut, and these did not exceed 50 pm in 
length. 
Transmission electron microscopy (Table 1). Twenty con-
secutive capillaries were photographed from thioflavin-
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Figure 2 (opposite page). A, Representative electron micrograph 
showing normal endothelium. B, Endothelium showing mild swell-
ing with decreased pinocytotic vesicles. C, Endothelium showing 
moderate cell swelling with a further decrease in pinocytotic vesi-
cles. D, Capillary with endothelial projections and membrane-bound 
vesicles (arrow). E, Representative capillaries demonstrating endo-
thelial cell protrusions (arrowheads) with red cell (R) plugging. F, 
Red cell (R) stacking with focal endothelial protrusions (arrowheads) 
and swelling. G, Capillary showing total obstruction by platelets (P) 
and fibrin deposition (arrowheads). H, Capillary showing total 
obstruction by white cells (W). I, Capillary with focal endothelial 
cell disruption (arrows). 
negative and thioflavin-positive areas along with repre-
sentative capillaries from nonischemic zones at 3,OOOx 
magnification. Capillary and myocyte injury were quanti-
tated (with the observer unaware of treatment) from electron 
micrographs with use of criteria identified in Table 1 and 
Figure 2. Each electron micrograph from the appropriate 
region was assigned a myocyte and endothelial cell score. 
These values were summed from each region (thioflavin-
negative and thioflavin-positive) and divided by the total 
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number of capillaries examined. The percent of capillaries 
showing endothelial cell injury from the thioflavin-negative 
and thioflavin-positive regions was also determined. 
Statistical analysis. Data are presented as the mean val-
ues ± SEM. Serial results among groups were analyzed by 
repeated measures two-way analysis of variance. If differ-
ences were statistically significant, further pairwise analysis 
was performed by a two-tailed t test. Comparisons between 
groups were analyzed by a nonpaired Student's t test with a 
two-tailed discriminant score. Probability values :50.05 were 
required for an assumption of statistical significance. 
Results 
Forty dogs underwent coronary occlusion and 16 were 
excluded from the study. Of these 16 dogs, 7 developed 
ventricular fibrillation during coronary occlusion (either 
oxygenated [n = 2] or unoxygenated [n = 1]), perfluoro-
chemical and control (n = 4) dogs and during reperfusion (1 
in each treatment group). Six dogs did not develop ST 
_---1---------1 -- -- ---
Figure 3. Hemodynamic changes in 
oxygenated (triangles) and unoxy-
genated (squares) perfluorochemical-
treated and control (circles) dogs 
during the experimental protocol. 
No significant differences between 
groups were noted in any of these 
variables. HR = heart rate; 0 = 
occlusion; SBP = systolic blood 
pressure. 
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Table 2. Hematologic Variables in Perfluorochemical-Treated and 
Control Dogs 
Baseline Reperfusion (ml!min per g) 
(ml!min 
per g) 30 min 210 min 
TLC (x 1<Pfmm3) 
PFC 5.6 ± 1.6 4.9 ± 0.9 14.1 ± 2.8 
PFC(-Oz) 5.5 ± 0.1 5.4 ± 0.9 10.2 ± 2.4 
Cont 5.9 ± 1.0 10.6 ± 2.8 19.8 ± 4.8 
HCT(%) 
PFC 41.7 ± 2.6 36.0 ± 1.9 41.8 ± 2.1 
PFC(-Oz) 41.2 ± 1.3 40.4 ± 2.2 43.3 ± 1.7 
Cont 36.5 ± 1.5 38.5 ± 1.6 38.7 ± 1.6 
Hb (gldl) 
PFC 14.3 ± 0.5 11.9 ± 0.6 13.7 ± 0.7 
PFC(-Oz) 15.1 ± 0.5 14.3 ± 0.8 15.2 ± 0.5 
Cont 12.6 ± 0.4 13.6 ± 0.5 13.6 ± 0.5 
Values are expressed as mean values ± SEM. Cont = control blood 
reperfusion group; Hb = hemoglobin; HCT = hematocrit; PFC = oxygenated 
perfluorochemical group; PFC( -Oz) = unoxygenated perfluorochemical 
group; TLC = total leukocyte count. 
segment elevation (2':2 m V) or a significant decrease in 
coronary blood pressure (2':70% of baseline value). Among 
the remaining 24 dogs included in the data analysis, 16 
underwent blood-free reperfusion with either oxygenated (n 
= 8) or unoxygenated (n = 8) intracoronary perfluorochem-
ical and 8 control dogs were reperfused with blood. 
Hemodynamic variables. Heart rate, systolic pressure, 
rate-pressure product (an indirect evaluation of myocardial 
oxygen consumption) and mean coronary pressure are 
shown in Figure 3. Hemodynamic variables were not signif-
icantly changed by intracoronary infusion of perfluorochem-
ical and were similar in all three groups throughout the 
duration of the study. Mean coronary blood pressure de-
creased dramatically in all groups at occlusion, whereas at 
reperfusion, coronary pressure was restored to its baseline 
value, indicating adequate reperfusion. 
Hematologic variables (Table 2). Baseline total leukocyte 
counts were similar in all groups. An increase in blood 
leukocytes was noted at 30 min of reperfusion only in control 
dogs (control group 10.6 ± 2.8 versus 4.9 ± 0.9 min in 
oxygenated and 5.4 ± 0.9 vs. unoxygenated perfluorochem-
ical groups). By 210 min of reperfusion, total leukocyte 
count increased in all groups and was maximal in control 
dogs. Hematocrit and hemoglobin values were similar at all 
time points except at 30 min of reperfusion in the oxygenated 
perfluorochemical group, where they were mildly depressed 
with respect to baseline values. The mean fluorocrit (similar 
to hematocrit, but applied to the percent of perfluorochem-
ical in the circulating blood) at 30 min of reperfusion was 
similar in both perfluorochemical groups and varied from 3% 
to 5%. 
Regional myocardial blood flow (Table 3). Baseline blood 
flow in endocardial and epicardial ischemic areas was similar 
in all treatment groups. All dogs developed a marked reduc-
tion in blood flow in the ischemic endocardial region at 
45 min of occlusion, consistent with relatively poor collateral 
circulation (0.19 ± 0.07, 0.20 ± 0.09 and 0.10 ± 0.03 mllmin 
per g in the control and oxygenated and unoxygenated 
perfluorochemical groups, respectively; p = NS). In the 
epicardial region, flow also decreased during occlusion, but 
the reduction was less severe than in the endocardium. In 
the endocardium, blood flow was similar at 30 min of 
reperfusion in dogs treated with oxygenated perfluorochem-
ical or blood reperfusion alone (1.02 ± 0.05 and 1.00 ± 
0.24 mllmin per g, respectively). However, in dogs treated 
with unoxygenated perfluorochemical, blood flow improved 
only marginally at 30 min of reperfusion (0.46 ± 0.20 mllmin 
per g). A significant decrease in blood flow (p < 0.04) 
occurred at 210 min of reperfusion in dogs treated with 
unoxygenated perfluorochemical or blood reperfusion alone, 
whereas blood flow in dogs treated with oxygenated perflu-
orochemical was remarkably preserved. 
Effects of perfluorochemical treatment on myocardial per-
fusion assessed by thioflavin staining. No significant differ-
ences were noted in left ventricular weight in all three 
Table 3. Regional Myocardial Blood Flow From Endocardial and Epicardial Sections Within the 
Ischemic Region 
Baseline 45 Min 
Reperfusion (ml!min per g) 
(ml!min per g) OcclUSIOn 30 min 210 min 
Endocardium 
PFC* 1.12 ± 0.15 0.20 ± 0.09 1.02 ± 0.05 0.97 ± 0.22t 
PFC(-02) 0.77 ± 0.01 0.10 ± 0.03 0.46 ± 0.20 0.29 ± 0.06 
Cont 1.47 ± 0.15 0.19 ± 0.07 1.00 ± 0.24 0.39 ± 0.08 
Epicardium 
PFC* 1.09 ± 0.11 0.25 ± 0.08 1.35 ± 0.05 1.16 ± 0.19 
PFC(-OzJ 0.83 ± 0.20 0.14 ± 0.03 0.65 ± 0.25 0.36 ± 0.04 
Cont 1.21 ± 0.24 0.37 ± 0.17 1.22 ± 0.55 0.62 ± 0.26 
*Endocardial and epicardial regions contained both thioflavin-negative and -positive areas. tp < 0.04 versus 
unoxygenated perfluorochemical (PFC-Oz) and control (Cont) groups. Values are expressed as mean values ± SEM. 
Myocardial blood flow in the nonischemic region (endocardial and epicardial sections) was similar at all time points 
(data not shown). PFC = oxygenated perfluorochemical group. 
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* p=ns } ** p=O. 004 vs. Control 
T-flV (%) 
PFC PFC(-021 Control 
Figure 4. Dogs treated with oxygenated perfluorochemical (PFC) 
showed a statistically significant decrease in thioflavin-negative 
areas (T -), when expressed as a percent of the total left ventricle 
(LV), in comparison with values in control animals. PFC( -02) = 
unoxygenated perfluorochemical. 
treatment groups (64.5 ± 0.04, 62.1 ± 0.06 and 61.3 ± 0.05 g 
in control and oxygenated and unoxygenated perfluoro-
chemical groups, respectively). A significant decrease in 
thioflavin-negative area (expressed as a percent of the left 
ventricle) was noted in dogs treated with oxygenated perfiu-
orochemical (3.1 ± 1.0%) compared with values in control 
dogs (9.8 ± 1.6%; p < 0.04) (Fig. 4). The size of thioflavin-
negative areas was reduced in dogs treated with unoxygen-
ated perfluorochemical (5.7 ± 1.5%) compared with the size 
in control dogs, but the difference did not reach statistical 
significance. 
Light microscopy (Table 4). A total of 800 capillaries/ 
heart were counted (200/histologic region). The mean num-
ber of neutrophils observed in capillaries was significantly 
greater in thioflavin-negative areas in control dogs (18.9 ± 
3.2) than in these areas in dogs receiving oxygenated or 
unoxygenated perfiuorochemical treatment (5.9 ± 1.4 and 
5.4 ± 0.8; p == 0.003 and 0.002, respectively). No significant 
Table 4. Quantitation by Light Microscopy of Polymorphonuclear 
Leukocyte Infiltration per 200 Capillaries Within (Ischemic) 
Thioflavin-Negative (T -) and Thioflavin-Positive (T +) and 
(Nonischemic) Endocardial and Epicardial Regions 
Ischemic Nonischemic 
T- Tt Endocardium Epicardium 
PFC 5.9 ± 1.4 4.7 ± 1.8 3.0 ± 0.8 1.4 ± 0.6 
PFC(-Oz) 5.4 ± 0.8 4.0 ± 0.5 1.3 ± 0.6 2.8 ± 0.8 
Cont 18.9 ± 3.2* 4.9 ± 1.1 2.7 ± 0.4 2.2 ± 1.0 
*p < 0.003 versus oxygenated perfluorochemical (PFC) group and p < 
0.002 versus unoxygenated perfluorochemical (PFC-Oz) group. Values are 
expressed as mean values ± SEM. Cont = control group. 
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Table 5. Quantitation of Capillary and Myocyte Injury by 
Electron Microscopy From Thioflavin-Negative (T-) and 
Thioflavin-Positive (T +) Areas Within the Ischemic Bed 
Endothelial Cell Injury 
T- Tt T+iMyocytes % Capillary Injury 
PFC 1.6 ± 0.2* 1.4 ± 0.2 1.0 ± 0.2 56.1 ± 6.1 
PFC(-Oz) 2.3 ± 0.2 1.4 ± 0.2 1.0 ± 0.2 79.8 ± 5.5 
Cont 2.5 ± 0.2 1.3 ± 0.2 1.1 ± 0.4 85 ± 3.8 
*p < 0.05 versus unoxygenated perfluorochemical (PFC-Oz) and control 
(Cont) groups. Values are expressed as mean values ± SEM. Endothelial cell 
injury was quantitated using the morphologic criteria outlined in Table 1. 
T+iMyocytes refers to a quantitative score of myocyte injury in thioflavin-
positive (T +) regions (no injury, score = 0; reversible injury, score = J; 
irreversible injury, score = 2). % Capillary Injury refers to the percent of 
endothelial cells showing injury in thioflavin-negative (T -) regions (score 2:: 
0.05). PFC = oxygenated perfluorochemical group. 
differences were noted in neutrophil plugging among the 
three treatment groups in thioflavin-positive and nonis-
chemic regions (endocardium and epicardium). 
Electron microscopy (Table 5). Twenty consecutive cap-
illaries from thioflavin-negative and thioflavin-positive areas 
were photographed and scored by the criteria outlined in 
Table 1. Thioflavin-negative areas uniformly showed irre-
versible myocyte injury in all treatment groups. Endothelial 
cell injury in these areas was maximal in dogs with blood 
reperfusion alone and was significantly less in dogs treated 
with oxygenated perfiuorochemical than in dogs in either the 
unoxygenated perfiuorochemical or control group (1.6 ± 0.2 
vs. 2.3 ± 0.2 and 2.5 ± 0.2, respectively; p < 0.05). No 
significant difference in capillary or myocyte injury was 
noted in thioflavin-positive areas among all three treatment 
groups. The percent of capillaries showing endothelial cell 
injury (mild to severe) was significantly decreased in the 
group treated with oxygenated perfiuorochemical (56.1 ± 
6.1 %) compared with values in both the unoxygenated 
perfiuorochemical (79.8 ± 5.5%) and control (85.0 ± 3.8%) 
groups (p < 0.05). 
Discussion 
Reduced no refiow injury after reperfusion with intracor-
onary oxygenated perfiuorochemical. This study demon-
strates that blood-free reperfusion with intracoronary oxy-
genated perfluorochemical administered over 20 min 
significantly reduces no reflow injury after 90 min of coro-
nary occlusion followed by 210 min ofreperfusion. This was 
evident as a significant reduction in the area of no reflow in 
dogs treated with oxygenated perfluorochemical compared 
with values in dogs receiving either unoxygenated perfiuo-
rochemical or blood reperfusion alone. Endocardial blood 
flow in the ischemic zone decreased progressively with 
reperfusion in control (blood-reperfused) and unoxygenated 
perfiuorochemical groups, but was maintained with oxygen-
ated perfluorochemical. These findings were associated with 
relative preservation of endothelial cell structure in the 
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oxygenated perfluorochemical group compared with the 
unoxygenated perfluorochemical and control groups. Recov-
ery of blood flow in endocardial and epicardial regions in 
dogs treated with unoxygenated perfluorochemical was less 
than in control dogs at both 30 and 210 min of reperfusion, 
possibly a result of an additional 20 min of ischemia. 
The number of capillaries containing leukocytes was 
significantly fewer in dogs treated with perfluorochemical 
compared with control dogs. These findings support the 
hypothesis that blood-free reperfusion with oxygenated per-
fluorochemical improves oxygen delivery to the microvas-
culature and protects the endothelium from further injury. 
Fewer leukocytes within capillaries may also have contrib-
uted to a decrease in no reflow in both perfluorochemical 
groups. However, preservation of endothelium was the 
predominant mechanism in limiting no reflow injury with 
oxygenated perfluorochemical. One may speculate that the 
other potential beneficial effects of blood-free reperfusion 
with perfluorochemical-washout of ischemic metabolites 
and depressed neutrophil function-are of secondary impor-
tance because dogs receiving unoxygenated perfluorochem-
ical did not show a statistically significant reduction in no 
reflow areas compared with control dogs. However, it must 
be recognized that dogs in the unoxygenated perfluorochem-
ical group were exposed to an additional 20 min of ischemia. 
Endothelium and reperfusion injury. The role of endothe-
lium during reperfusion has long been of interest. Although 
early reperfusion reduces infarct size, improves ventricular 
function and reduces the incidence of death (14-16), the 
introduction of oxygen and blood elements (especially neu-
trophils) into the ischemic myocardium has been reported 
(17-20) to induce deleterious effects in the microvascular 
bed. We hypothesize that endothelial injury may be the 
critical factor in the no reflow phenomenon. Moreover, the 
degree of endothelial injury appears to be dependent on the 
duration of coronary occlusion. Kloner et al. (5), using 
thioflavin-S as a marker, were unable to demonstrate no 
reflow after 40 min of coronary occlusion, but 90 min 
resulted in a marked heterogeneity of blood flow to the 
previously ischemic myocardium. Histologic analysis of no 
reflow areas revealed numerous structural abnormalities in 
endothelial cells (5). 
The emphasis on endothelial injury as the basis of the 
transformation of reversibly injured myocytes into irrevers-
ibly injured cells during reperfusion is in contrast to earlier 
studies (21) with permanent coronary occlusion, which 
showed that myocyte injury precedes microvascular injury. 
However, not all endothelial cells within the ischemic region 
are affected at the same time or to a similar extent. Kloner et 
al. (6) also reported that ultrastructural irreversible myocyte 
injury becomes evident in the subendocardium by 40 min of 
ischemia; however, capillary changes were not seen until 60 
to 90 min of ischemia. At 60 min of coronary occlusion, 
endothelial changes in capillaries were present in approxi-
mately 20% of vessels, and by 90 to 180 minutes, 40% of 
vessels showed microvascular injury (6). In the present 
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study, 85% of capillaries showed some degree of endothelial 
injury after 90 min of coronary occlusion followed by 
210 min of blood reperfusion. Therefore, although it appears 
that capillary injury lags behind myocyte injury, there is 
considerable overlap. 
We postulate that myocardial salvage with reperfusion 
should occur in areas where myocardial cells are reversibly 
injured and contain a relatively intact microvasculature. 
After reperfusion, reversibly injured myocytes may be con-
verted to irreversibly injured cells, and the ischemic mi-
crovasculature probably plays a fundamental role through 
endothelial cell swelling, vascular plugging by cellular blood 
elements or explosive myocyte swelling that is capable of 
compressing adjacent capillaries (5,19). 
Ambrosio et al. (22) observed a progressive decrease in 
postischemic blood flow after 90 min of coronary occlusion 
and 210 min of reperfusion. This correlated with large 
perfusion defects identified by lack of thioflavin-S staining. 
Our observations were similar with 210 min of reperfusion in 
the control dogs (with blood reperfusion). Because myocar-
dial blood flow was comparable during coronary occlusion in 
all three treatment groups in our study, myocyte ischemic 
injury must also have been similar before reperfusion. Ear-
lier studies with perfluorochemicals in our laboratory (9,10) 
measured serial changes in myocardial blood flow in the 
ischemic myocardium with use of both xenon-133 and radio-
active microspheres. Myocardial blood flow at reperfusion 
was greater in dogs treated with perfluorochemical than in 
those treated with crystalloid therapy; however, these data 
were limited to measurement of flow only up to 60 min of 
reperfusion (9,10). The present study extends these obser-
vations to 210 min of reperfusion and demonstrates a signif-
icant decrease in the no reflow areas with oxygenated 
perfluorochemical. 
Perfluorochemicals (mechanism of action). Perfluoro-
chemicals have been shown to reduce infarct size and 
improve contractile function in various models of occlusion 
and reperfusion (7-10,23). However, the precise mechanism 
involved in limiting reperfusion injury is still not known. 
Because the perfluorochemical Fluosol-DA has a small par-
ticle size (1 to 2 pm) and low viscosity, it would be expected 
to increase oxygen delivery to ischemic tissue (24). In 
reperfusion, perfluorochemical may provide oxygen to areas 
of the microcirculation inaccessible to red blood cells as a 
result of anoxia and red and white cell sludging. Indeed, 
enhancement of myocardial oxygen delivery by perfluoro-
chemical has been shown in the central ischemic zone in a 
model of permanent occlusion (24). 
We previously demonstrated (7-10) that large and inter-
mediate doses of perfluorochemical administered intrave-
nously or by the intracoronary route significantly reduced 
neutrophil infiltration in models of permanent and temporary 
occlusion. In addition, neutrophil chemotaxis and lysosomal 
enzyme release were also markedly suppressed with perflu-
orochemical ex vivo (10). In the present study, leukocytosis 
was delayed in addition to a decrease in capillary plugging by 
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neutrophils with perfluorochemical treatment compared with 
blood reperfusion (control) treatment. Although the number 
of leukocytes in capillaries was decreased similarly in both 
oxygenated and unoxygenated perfluorochemical-treated 
groups with respect to values in the control group, no 
significant differences were noted in thioflavin-negative ar-
eas between unoxygenated perfluorochemical-treated and 
control groups. We hypothesize that leukocyte infiltration 
and capillary plugging in the reperfused myocardium are 
inhibited by perfluorochemical; oxygenation of perfluoro-
chemical offers the additional advantage of endothelial pres-
ervation. Together, these effects on leukocytes and endothe-
lial cells may be crucial factors in the limitation of 
reperfusion injury by perfluorochemical. 
Limitations of the study. Several considerations need to 
be discussed before acceptance of the methods in the present 
study. The canine infarct model is predisposed to a high 
degree of collateral circulation, with marked variation 
among dogs. In the present study, myocardial blood flow 
during coronary occlusion was similar among all three 
treatment groups. Therefore, we assumed that all dogs were 
subjected to similar degrees of ischemia. We did not normal-
ize thioflavin-negative areas as a percent of the area at risk. 
Previous canine studies (8,10,11) have shown that infarcted 
myocardium, when expressed as a percent of the area at 
risk, correlates well with myocardial blood flow. These 
studies (8,10,11) also demonstrated significant infarct size 
reduction when the infarcted area was expressed as a 
percent of the left ventricle. In addition, colored dyes 
normally used to measure risk regions may interfere with the 
fluorescence staining imparted by thioflavin-S. Finally, al-
though lidocaine has been reported (25) to reduce infarct 
size, in the present study, lidocaine was administered in 
equivalent concentrations in all three treatment groups and 
therefore its effects, if any, should have been equally dis-
tributed. 
Conclusions. Preservation of the ischemic myocardium 
with oxygenated perfluorochemical may limit myocardial 
necrosis by decreasing infarct extension during reperfusion. 
Our results show that the oxygenated perfluorochemical 
Fluosol-DA 20% may hold considerable promise in reducing 
reperfusion injury and may be a useful adjunct therapy to 
thrombolytic agents in the treatment of myocardial infarc-
tion in patients. Improvement of myocardial perfusion 
through capillary preservation in previously ischemic tissue 
may also facilitate the delivery of other cardioprotective 
drugs. 
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